Literature DB >> 22518839

Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction.

David M Cauvi1, Donghuan Song, Daniel E Vazquez, Dennis Hawisher, Jose A Bermudez, Michael R Williams, Stephen Bickler, Raul Coimbra, Antonio De Maio.   

Abstract

Sepsis is a major health problem in the United States with high incidence and elevated patient care cost. Using an animal model of sepsis, cecum ligation, and puncture, we observed that mice became rapidly hypothermic reaching a threshold temperature of 28 °C within 5-10 h after initiation of the insult, resulting in a reliable predictor of mortality, which occurred within 30-72 h of the initial procedure. We also observed that the inflammatory gene expression in lung and liver developed early within 1-2 h of the insult, reaching maximum levels at 6 h, followed by a decline, approaching basal conditions within 20 h. This decrease in inflammatory gene expression at 20 h after cecal ligation and puncture was not due to resolution of the insult but rather was an immune dysfunction stage that was demonstrated by the inability of the animal to respond to a secondary external inflammatory stimulus. Removal of the injury source, ligated cecum, within 6 h of the initial insult resulted in increased survival, but not after 20 h of cecal ligation and puncture. We concluded that the therapeutic window for resolving sepsis is early after the initial insult and coincides with a stage of hyperinflammation that is followed by a condition of innate immune dysfunction in which reversion of the outcome is no longer possible.

Entities:  

Mesh:

Year:  2012        PMID: 22518839      PMCID: PMC3370166          DOI: 10.1074/jbc.M112.359562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

Review 2.  Endotoxin tolerance: new mechanisms, molecules and clinical significance.

Authors:  Subhra K Biswas; Eduardo Lopez-Collazo
Journal:  Trends Immunol       Date:  2009-09-24       Impact factor: 16.687

3.  Relationships between T lymphocyte apoptosis and anergy following trauma.

Authors:  J D Pellegrini; A K De; K Kodys; J C Puyana; R K Furse; C Miller-Graziano
Journal:  J Surg Res       Date:  2000-02       Impact factor: 2.192

4.  Selective defects of T lymphocyte function in patients with lethal intraabdominal infection.

Authors:  C D Heidecke; T Hensler; H Weighardt; N Zantl; H Wagner; J R Siewert; B Holzmann
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

5.  Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.

Authors:  C A Gogos; E Drosou; H P Bassaris; A Skoutelis
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  The OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity.

Authors:  Ian G Stiell; Lisa P Nesbitt; William Pickett; Douglas Munkley; Daniel W Spaite; Jane Banek; Brian Field; Lorraine Luinstra-Toohey; Justin Maloney; Jon Dreyer; Marion Lyver; Tony Campeau; George A Wells
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

7.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

8.  PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.

Authors:  Xin Huang; Fabienne Venet; Yvonne L Wang; Alain Lepape; Zhenglong Yuan; Yaping Chen; Ryan Swan; Hakim Kherouf; Guillaume Monneret; Chun-Shiang Chung; Alfred Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

9.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834

10.  Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis.

Authors:  Uwe Koedel; Tobias Frankenberg; Susanne Kirschnek; Bianca Obermaier; Hans Häcker; Robert Paul; Georg Häcker
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  16 in total

1.  What can we learn from elegant clinical studies?*.

Authors:  Antonio De Maio
Journal:  Crit Care Med       Date:  2014-04       Impact factor: 7.598

2.  Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Authors:  Evelyn E Nash; Brian M Peters; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

3.  COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?

Authors:  Antonio De Maio; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2020-09       Impact factor: 3.667

4.  Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.

Authors:  Jonathan L Halbach; Andrew W Wang; Dennis Hawisher; David M Cauvi; Radhames E Lizardo; Joseph Rosas; Tony Reyes; Omar Escobedo; Stephen W Bickler; Raul Coimbra; Antonio De Maio
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

5.  Regulation of the Nfkbiz Gene and Its Protein Product IkBζ in Animal Models of Sepsis and Endotoxic Shock.

Authors:  Arturo Casas; Dennis Hawisher; Christian B De Guzman; Stephen W Bickler; Antonio De Maio; David M Cauvi
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

6.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

7.  The GTPase Rab1 Is Required for NLRP3 Inflammasome Activation and Inflammatory Lung Injury.

Authors:  Yuehui Zhang; Lijun Wang; Yang Lv; Chunling Jiang; Guangyu Wu; Randal O Dull; Richard D Minshall; Asrar B Malik; Guochang Hu
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

8.  The Contribution of the Omentum to the Outcome From Sepsis: An Experimental Animal Study.

Authors:  Andrew W Wang; David M Cauvi; Dennis Hawisher; Tony Reyes; Raul Coimbra; Stephen Bickler; Antonio De Maio
Journal:  Shock       Date:  2019-12       Impact factor: 3.454

9.  Post challenge inhibition of C3 and CD14 attenuates Escherichia coli-induced inflammation in human whole blood.

Authors:  Kjetil H Egge; Ebbe B Thorgersen; Julie K Lindstad; Anne Pharo; John D Lambris; Andreas Barratt-Due; Tom E Mollnes
Journal:  Innate Immun       Date:  2013-05-13       Impact factor: 2.680

10.  Elevated expression of IL-23/IL-17 pathway-related mediators correlates with exacerbation of pulmonary inflammation during polymicrobial sepsis.

Authors:  David M Cauvi; Michael R Williams; Jose A Bermudez; Gabrielle Armijo; Antonio De Maio
Journal:  Shock       Date:  2014-09       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.